1. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. (1st October 2017) Authors: Li, S.; Villarreal, M.; Stewart, S.; Choi, J.; Ganguli‐Indra, G.; Babineau, D.C.; Philpot, C.; David, G.; Yoshida, T.; Boguniewicz, M.; Hanifin, J.M.; Beck, L.A.; Leung, D.Y.; Simpson, E.L.; Indra, A.K. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: e125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. (5th September 2017) Authors: Li, S.; Villarreal, M.; Stewart, S.; Choi, J.; Ganguli‐Indra, G.; Babineau, D.C.; Philpot, C.; David, G.; Yoshida, T.; Boguniewicz, M.; Hanifin, J.M.; Beck, L.A.; Leung, D.Y.; Simpson, E.L.; Indra, A.K. Journal: British journal of dermatology Issue: Volume 177:Number 4(2017) Page Start: e125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing the need for routine safety testing for patients being treated with dupilumab for moderate‐to‐severe atopic dermatitis. (1st June 2020) Authors: Wollenberg, A; Beck, L.A.; Blauvelt, A.; Simpson, E.L.; Chen, Z.; Chen, Q.; Shumel, B.; Khokhar, F.A.; Hultsch, T.; Rizova, E.; Rossi, A.B.; Graham, N.M.H.; Pirozzi, G.; Lu, Y.; Ardeleanu, M. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: e186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon‐γ‐producing CD8+ T cells. (30th August 2013) Authors: Mathias, R.A.; Weinberg, A.; Boguniewicz, M.; Zaccaro, D.J.; Armstrong, B.; Schneider, L.C.; Hata, T.R.; Hanifin, J.M.; Beck, L.A.; Barnes, K.C.; Leung, D.Y.M. Journal: British journal of dermatology Issue: Volume 169:Number 3(2013:Sep.) Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (1st August 2020) Authors: Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (5th March 2020) Authors: Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bullous pemphigoid associated with nivolumab, a programmed cell death 1 protein inhibitor. (3rd March 2017) Authors: Kwon, C.W.; Land, A.S.; Smoller, B.R.; Scott, G.; Beck, L.A.; Mercurio, M.G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 8(2017) Page Start: e349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials. (1st March 2022) Authors: Wollenberg, A.; Beck, L.A.; de Bruin Weller, M.; Simpson, E.L.; Imafuku, S.; Boguniewicz, M.; Zachariae, R.; Olsen, C.K.; Thyssen, J.P. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials. (28th November 2021) Authors: Wollenberg, A.; Beck, L.A.; de Bruin Weller, M.; Simpson, E.L.; Imafuku, S.; Boguniewicz, M.; Zachariae, R.; Olsen, C.K.; Thyssen, J.P. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials. (7th September 2020) Authors: Beck, L.A.; Silverberg, J.I.; Simpson, E.L.; Yosipovitch, G.; Eckert, L.; Guillemin, I.; Chen, Z.; Ardeleanu, M.; Plaum, S.; Graham, N.; Ruddy, M.; Pirozzi, G.; Gadkari, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: e130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗